[Elsevier] Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

scihub0903 Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-14 18:04
Reward10points

Clinical Trial
Lancet Diabetes Endocrinol




. 2022 Jun;10(6):418-429.

doi: 10.1016/S2213-8587(22)00085-7. Epub 2022 Apr 22.Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trialTim Heise 1, Andrea Mari 2, J Hans DeVries 1, Shweta Urva 3, Jing Li 3, Edward John Pratt 3, Tamer Coskun 3, Melissa K Thomas 3, Kieren J Mather 3, Axel Haupt 3, Zvonko Milicevic 4



  • PMID: 35468322

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    6130


Return to the list